Revvity, Inc.

Symbol: RVTY

NYSE

104.34

USD

Market price today

  • 85.4676

    P/E Ratio

  • 5.4699

    PEG Ratio

  • 12.89B

    MRK Cap

  • 0.00%

    DIV Yield

Revvity, Inc. (RVTY) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.49%

Operating Profit Margin

0.10%

Net Profit Margin

0.06%

Return on Assets

0.01%

Return on Equity

0.02%

Return on Capital Employed

0.02%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Dr. Prahlad R. Singh Ph.D.
Full-time employees:11000
City:Waltham
Address:940 Winter Street
IPO:1965-07-06
CIK:0000031791

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

General Outlook

When we look at how much money they make before expenses, they keep 0.489% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.099%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.056%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.011% return, is a testament to Revvity, Inc.'s adeptness in optimizing resource deployment. Revvity, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.019%. Furthermore, the proficiency of Revvity, Inc. in capital utilization is underscored by a remarkable 0.022% return on capital employed.

Stock Prices

Revvity, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $104.54, while its low point bottomed out at $101.72. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Revvity, Inc.'s stock market.

Liquidity Ratios

Analyzing RVTY liquidity ratios reveals its financial health of the firm. The current ratio of 222.62% gauges short-term asset coverage for liabilities. The quick ratio (166.33%) assesses immediate liquidity, while the cash ratio (72.73%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio222.62%
Quick Ratio166.33%
Cash Ratio72.73%

Profitability Ratios

RVTY profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 6.90% underscores its earnings before tax deductions. The effective tax rate stands at 2.52%, revealing its tax efficiency. The net income per EBT, 80.98%, and the EBT per EBIT, 70.03%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 9.85%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin6.90%
Effective Tax Rate2.52%
Net Income per EBT80.98%
EBT per EBIT70.03%
EBIT per Revenue9.85%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.23, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 462.78% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding166
Days of Inventory Outstanding108
Operating Cycle187.35
Days of Payables Outstanding48
Cash Conversion Cycle139
Receivables Turnover4.63
Payables Turnover7.59
Inventory Turnover3.36
Fixed Asset Turnover4.18
Asset Turnover0.20

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.41, and free cash flow per share, 0.78, depict cash generation on a per-share basis. The cash per share value, 13.60, showcases liquidity position. A payout ratio of 0.23 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.06, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.41
Free Cash Flow per Share0.78
Cash per Share13.60
Payout Ratio0.23
Operating Cash Flow Sales Ratio0.06
Free Cash Flow to Operating Cash Flow Ratio0.55
Cash Flow Coverage Ratio0.05
Short Term Coverage Ratio0.25
Capital Expenditure Coverage Ratio2.24
Dividend Paid and Capex Coverage Ratio1.55

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 28.86%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.49, we discern the balance between debt and equity financing. The long-term debt to capitalization, 28.74%, and total debt to capitalization, 33.07%, ratios shed light on its capital structure. An interest coverage of 2.67 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio28.86%
Debt Equity Ratio0.49
Long Term Debt to Capitalization28.74%
Total Debt to Capitalization33.07%
Interest Coverage2.67
Cash Flow to Debt Ratio0.05
Company Equity Multiplier1.71

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 22.06, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.44, reflects the portion of profit attributed to each share. The book value per share, 63.13, represents the net asset value distributed per share, while the tangible book value per share, -13.50, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share22.06
Net Income Per Share1.44
Book Value Per Share63.13
Tangible Book Value Per Share-13.50
Shareholders Equity Per Share63.13
Interest Debt Per Share32.06
Capex Per Share-0.65

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -16.95%, indicates top-line expansion, while the gross profit growth, -40.97%, reveals profitability trends. EBIT growth, -59.53%, and operating income growth, -59.53%, offer insights into operational profitability progression. The net income growth, -68.46%, showcases bottom-line expansion, and the EPS growth, -68.07%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-16.95%
Gross Profit Growth-40.97%
EBIT Growth-59.53%
Operating Income Growth-59.53%
Net Income Growth-68.46%
EPS Growth-68.07%
EPS Diluted Growth-68.00%
Weighted Average Shares Growth-1.15%
Weighted Average Shares Diluted Growth-1.28%
Dividends per Share Growth0.08%
Operating Cash Flow Growth-86.57%
Free Cash Flow Growth-98.33%
10-Year Revenue Growth per Share14.30%
5-Year Revenue Growth per Share-12.22%
3-Year Revenue Growth per Share-34.98%
10-Year Operating CF Growth per Share-48.19%
5-Year Operating CF Growth per Share-73.98%
3-Year Operating CF Growth per Share-90.85%
10-Year Net Income Growth per Share-1.96%
5-Year Net Income Growth per Share-33.11%
3-Year Net Income Growth per Share-77.95%
10-Year Shareholders Equity Growth per Share255.75%
5-Year Shareholders Equity Growth per Share170.02%
3-Year Shareholders Equity Growth per Share88.46%
10-Year Dividend per Share Growth per Share-0.40%
5-Year Dividend per Share Growth per Share-0.03%
3-Year Dividend per Share Growth per Share0.18%
Receivables Growth3.27%
Inventory Growth5.57%
Asset Growth-3.98%
Book Value per Share Growth7.73%
Debt Growth-11.65%
R&D Expense Growth-2.27%
SGA Expenses Growth-35.89%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 16,889,078,720, captures the company's total value, considering both debt and equity. Income quality, 0.51, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 70.45%, indicates the value of non-physical assets, and capex to operating cash flow, -89.15%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value16,889,078,720
Income Quality0.51
Research and Development to Revenue7.87%
Intangibles to Total Assets70.45%
Capex to Operating Cash Flow-89.15%
Capex to Revenue-2.96%
Capex to Depreciation-18.85%
Stock-Based Compensation to Revenue1.51%
Graham Number45.22
Return on Tangible Assets4.48%
Graham Net Net-27.26
Working Capital1,550,628,000
Tangible Asset Value-1,683,132,000
Net Current Asset Value-2,690,835,000
Average Receivables622,795,500
Average Payables238,473,500
Average Inventory416,762,000
Days Sales Outstanding84
Days Payables Outstanding47
Days of Inventory On Hand99
ROIC2.50%
ROE0.02%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.66, and the price to book ratio, 1.66, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.73, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 132.73, and price to operating cash flows, 74.23, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.66
Price to Book Ratio1.66
Price to Sales Ratio4.73
Price Cash Flow Ratio74.23
Price Earnings to Growth Ratio5.47
Enterprise Value Multiple13.34
Price Fair Value1.66
Price to Operating Cash Flow Ratio74.23
Price to Free Cash Flows Ratio132.73
Price to Tangible Book Ratio1.75
Enterprise Value to Sales6.14
Enterprise Value Over EBITDA23.06
EV to Operating Cash Flow185.04
Earnings Yield1.30%
Free Cash Flow Yield0.07%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Revvity, Inc. (RVTY) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 85.468 in 2024.

What is the ticker symbol of Revvity, Inc. stock?

The ticker symbol of Revvity, Inc. stock is RVTY.

What is company IPO date?

IPO date of Revvity, Inc. is 1965-07-06.

What is company current share price?

Current share price is 104.340 USD.

What is stock market cap today?

The market cap of stock today is 12888598500.000.

What is PEG ratio in 2024?

The current 5.470 is 5.470 in 2024.

What is the number of employees in 2024?

In 2024 the company has 11000.